As of Nov 21, 2024, the Iqvia Holdings stock's PE ratio is 25.63. This takes into account the latest EPS of $7.71 and stock price of $197.6. The PE ratio marks a decrease of 17% from its last 4 quarters average of 30.8.
The PE ratio of Iqvia Holdings has averaged 165.83 over the last ten years. The current P/E ratio of 25.63 is 85% lower than the historical average. Looking back at the last ten years, IQV's PE ratio peaked in the Mar 2017 quarter at 4,026.5, when the price was $80.53 and the EPS was $0.02. The lowest point was in the Dec 2017 quarter, when it reached 16.71 with a price of $97.9 and an EPS of $5.86.
Maximum annual increase: 626.79% in 2016
Maximum annual decrease: -89.45% in 2017
Year | PE ratio | Change |
---|---|---|
2023 | 31.31 | -11.05% |
2022 | 35.2 | -37% |
2021 | 55.87 | -54.47% |
2020 | 122.72 | -22.16% |
2019 | 157.66 | 72.36% |
2018 | 91.47 | 447.4% |
2017 | 16.71 | -89.45% |
2016 | 158.44 | 626.79% |
2015 | 21.8 | 2.93% |
2014 | 21.18 | -16.35% |
IQV's current PE ratio is lower than its 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
IQV Iqvia Holdings Inc | 25.63 | $35.86B |
OMIC Singular Genomics Systems Inc | N/A | $55.01M |
NWBO Northwest Biotherapeutics Inc | N/A | $367.18M |
The price to earnings ratio for IQV stock as of Nov 21, 2024, stands at 25.63.
Over the last 3 years, the average price to earnings ratio for IQV stock is 35.44.
Over the last 5 years, the average price to earnings ratio for IQV stock is 70.18.
Over the last ten years, the Mar 2017 quarter recorded the highest quarterly PE ratio at 4,026.5.
IQV's price to earnings ratio is currently 85% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 21, 2024), Iqvia Holdings's share price is $197.6. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $7.71. Therefore, Iqvia Holdings's PE ratio for today is 25.63. PE RATIO(25.63) = STOCK PRICE($197.6) / TTM EPS($7.71)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.